carmustine has been researched along with squalene in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benike, CJ; Caspar, CB; Czerwinsk, DK; Davis, TA; Engleman, EG; Hsu, FJ; Levy, R; Liles, TM; Taidi, B; van Beckhoven, A | 1 |
1 trial(s) available for carmustine and squalene
Article | Year |
---|---|
Idiotype vaccination following ABMT can stimulate specific anti-idiotype immune responses in patients with B-cell lymphoma.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Antibodies, Anti-Idiotypic; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Dendritic Cells; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Hemocyanins; Humans; Ifosfamide; Immunity, Cellular; Immunoglobulin Idiotypes; Lymphocyte Activation; Lymphoma, B-Cell; Male; Polysorbates; Receptors, Antigen, B-Cell; Safety; Squalene; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vaccination; Whole-Body Irradiation | 2001 |